세계의 모르키오 증후군 치료 시장 - 규모, 점유율, 성장 분석(치료법별, 질환유형별, 유통 채널별, 지역별) : 산업 예측(2025-2032년)
Morquio Syndrome Treatment Market Size, Share, Growth Analysis, By Treatment (Enzyme Replacement Therapy, Others), By Disease Type (Morquio A, Morquio B), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1624037
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 165 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 모르키오 증후군 치료 시장 규모는 2023년 1억 5,560만 달러로 평가되었으며, 2024년 1억 6,462만 달러에서 2032년에는 2억 5,845만 달러로 성장하고 예측 기간 중(2025-2032년)에 CAGR 5.8%로 성장할 전망입니다.
뮤코다당류증(MPS IV) 으로 분류되는 모르키오 증후군은 주로 골격에 영향을 미치는 드문 유전성 대사 이상증으로, 글리코사미노글리칸을 대사할 수 없는 체질을 특징으로 합니다. 현장은 유병률 상승, 정부와 기업의 지원 증가, 합병증에 대처하는 특수한 약제에 대한 수요가 높아짐에 따라 현저한 성장을 이루고 있습니다. 의료비 증가나 기술의 진보에 힘입어, 또, 치료의 선택지를 늘리는 것을 목적으로 하고 있습니다. 임상시험도 확대하고 있어, 2022년부터 2028년에 걸쳐 유리한 기회를 가져오면 하지만 불충분한 상환 정책과 높은 제조 비용 등의 과제는 시장의 확대를 저해할 가능성이 있고, 치료 선택에 관한 일반 시민의 의식의 낮음도 이에 박차를 가하고 있습니다.
목차
소개
분석 목적
시장 범위
정의
분석 기법
정보 조달
2차·1차 데이터의 수법
시장 규모 예측
시장의 상정과 제약
주요 요약
시장 개요와 전망
수급 동향의 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter's Five Forces 분석
시장의 주요 고려사항
주요 성공 요인
경쟁도
주요 투자 기회
시장 생태계
시장 매력도 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
특허 분석
사례 연구
세계의 모르키오 증후군 치료 시장 규모·CAGR : 치료법별(2025-2032년)
시장 개요
효소 보충 요법
기타
세계의 모르키오 증후군 치료 시장 규모·CAGR : 질환유형별(2025-2032년)
시장 개요
모르키오 A
모르키오 B
세계의 모르키오 증후군 치료 시장 규모·CAGR : 유통 채널별(2025-2032년)
시장 개요
병원 약국
소매 약국
온라인 약국
기타
세계의 모르키오 증후군 치료 시장 규모·CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 구도
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 기업이 채용한 전략
시장의 최근 동향
주요 기업의 시장 점유율(2024년)
주요 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2022-2024년)
주요 기업 프로파일
BioMarin Pharmaceuticals Inc.(미국)
Genzyme Corporation(미국)
Shire plc(Ireland)
JCR Pharmaceuticals Co., Ltd.(일본)
Sanofi(프랑스)
Sangamo Therapeutics(미국)
ArmaGen, Inc.(미국)
GREEN CROSS CORP(한국)
Concert Pharmaceuticals Inc.(미국)
Alexion Pharmaceuticals Inc.(미국)
Novo Nordisk A/S(덴마크)
Eli Lilly and Company(미국)
Boehringer Ingelheim International GmbH(독일)
AstraZeneca(UK)
Amgen Inc.(미국)
Merck KGaA(독일)
Actelion Pharmaceuticals Ltd.(스위스)
Biocon(인도)
Ultragenyx Pharmaceutical Inc.(미국)
Enzyvant Therapeutics Inc.(미국)
결론과 권장사항
JHS
영문 목차
영문목차
Global Morquio Syndrome Treatment Market size was valued at USD 155.6 million in 2023 and is poised to grow from USD 164.62 million in 2024 to USD 258.45 million by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).
Morquio syndrome, categorized under mucopolysaccharidosis (MPS IV), is a rare inherited metabolic disorder primarily affecting the skeleton, characterized by the body's inability to metabolize glycosaminoglycans. The global treatment market for Morquio syndrome is witnessing significant growth driven by the rising prevalence of the condition, increased governmental and corporate support, and heightened demand for specialized medications addressing its complications. Strategic mergers and partnerships among manufacturers aim to enhance treatment options, supported by rising healthcare expenditure and technological advancements. Clinical trials are also expanding, presenting lucrative opportunities from 2022 to 2028. However, challenges such as inadequate reimbursement policies and high production costs may impede market expansion, compounded by low public awareness regarding treatment options.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Morquio Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Morquio Syndrome Treatment Market Segmental Analysis
Global Morquio Syndrome Treatment Market is segmented by Treatment, Disease Type, Distribution Channel and region. Based on Treatment, the market is segmented into Enzyme Replacement Therapy and Others. Based on Disease Type, the market is segmented into Morquio A and Morquio B. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Morquio Syndrome Treatment Market
The Morquio Syndrome Treatment market is anticipated to experience significant growth, driven primarily by an upsurge in the number of therapeutic products entering both early and advanced research stages. There is an increasing emphasis on addressing rare diseases, which further fuels market expansion. Numerous pharmaceutical companies are actively developing new medications that, depending on their clinical trial outcomes, are expected to receive regulatory approvals. The recent authorization of elosulfase alfa (VIMIZIM) underscores the potential for additional treatments to reach the market, which is expected to stimulate interest and investment in Morquio Syndrome therapies.
Restraints in the Global Morquio Syndrome Treatment Market
One significant challenge facing the global Morquio Syndrome treatment market is the prohibitive cost associated with treatment options, notably VIMIZIM, which can reach approximately US$ 380,000 per year for patients. This financial burden limits accessibility for many who require these therapies. Furthermore, the market is hindered by a lack of awareness surrounding Morquio Syndrome in developing regions, which contributes to delayed diagnoses and treatments. Additionally, various clinical and regulatory challenges present further obstacles to market growth, complicating the landscape for both patients and healthcare providers seeking effective therapeutic solutions for this rare condition.
Market Trends of the Global Morquio Syndrome Treatment Market
The Global Morquio Syndrome Treatment market is experiencing a notable upward trend, driven by heightened research and development activities from key players and recent regulatory advancements. Pharmaceutical companies, including Ultragenyx Pharmaceutical Inc. and Shire, are actively conducting Phase 3 studies and clinical trials targeting various demographics affected by the syndrome. Moreover, innovative treatments, such as AGT 181 from ArmaGen, are emerging through clinical testing, reflecting a growing commitment to addressing this rare genetic disorder. Increased public awareness and understanding of Morquio syndrome further propel market growth, signaling a promising future for effective treatment options and improving patient outcomes.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies
Global Morquio Syndrome Treatment Market Size by Treatment & CAGR (2025-2032)
Market Overview
Enzyme Replacement Therapy
Others
Global Morquio Syndrome Treatment Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Morquio A
Morquio B
Global Morquio Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Morquio Syndrome Treatment Market Size & CAGR (2025-2032)
North America (Treatment, Disease Type, Distribution Channel)
US
Canada
Europe (Treatment, Disease Type, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Treatment, Disease Type, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Treatment, Disease Type, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Treatment, Disease Type, Distribution Channel)
